Q1 EPS Forecast for Sage Therapeutics Boosted by Analyst
Sage Therapeutics, Inc. (NASDAQ:SAGE – Free Report) – Equities research analysts at HC Wainwright raised their Q1 2025 earnings per share estimates for Sage Therapeutics in a report released on Wednesday, February 12th. HC Wainwright analyst D. Tsao now anticipates that the biopharmaceutical company will earn ($1.11) per share for the quarter, up from their […]
Sage Therapeutics, Inc. (NASDAQ:SAGE – Free Report) – Equities research analysts at HC Wainwright raised their Q1 2025 earnings per share estimates for Sage Therapeutics in a report released on Wednesday, February 12th. HC Wainwright analyst D. Tsao now anticipates that the biopharmaceutical company will earn ($1.11) per share for the quarter, up from their […]
